Skip to content

Effectiveness of APARPINDA TAILAM enema therapy for VATARAKTA-GOUT

RANDOMIZED OPEN CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF APARPINDA TAILAM MATRA BASTI IN VATARAKTA WITH SPECIAL REFERENCE TO GOUT - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102887
Enrollment
70
Registered
2026-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

Dr Shravani sunil patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting clinical sign and symptoms specific with Toda shotha Supti Daha Sthabdhata in vatarakta Serum uric acid range more than 7mg per dl in male More than 6mg per dl in female Irrespective of gender and religions Basti Aarha

Exclusion criteria

Exclusion criteria: Subjects with Known case of Amavata Sandhigatavata SLE Pregnant and Lactating women menstruating women Subjects associated with systemic disease like uncontrolled HTN and DM Chronic renal failure.

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Aparpinda Tailam matra basti in Vatarakta w.s.r Gout.Timepoint: 8days

Secondary

MeasureTime frame
1. To reduce sign and symptoms of vatarakta 2. To assess improvement by sign, symptoms and gradation of assessment criteria. 3. To study etiopathogenesiss of vatarakta vyadhi indetail from ayurvedic text books. 4. To improve quality of life and reduce discomfort of patient. 5. To evaluate clinically vatarakta with both ayurvedic and allopathy perspective using subjective and Objective parameter. 6. To study karmukta of Aparpinda Tailam Matra Basti in details from classical textbooks.Timepoint: 8days

Countries

India

Contacts

Public ContactDr Shravani sunil patil

Yashwant Ayurvedic college and post graduate training and research centre,kodoli

vaidyaravipatil@gmail.com9822010316

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026